Stockyfly One Page Analysis | Buy Stocks today

24/10/2025

Natco Pharma Ltd

BSE: 524816 NSE: NATCOPHARM

Pharmaceuticals

Financial Health Score: 56%

About the Company

NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. NATCO has established its presence in all three business segments viz. finished dosage formulations (“FDF”), active pharmaceutical ingredients (“APIs”), Contract Manufacturing Business.

Pros

Company has reduced debt.
Company is almost debt free.
Company has delivered good profit growth of 31.0% CAGR over last 5 years

Cons

Stock PE: 10.2

ROCE: 31.8

Market Cap: 15489 Cr.

Book Value: 462

ROE: 27.5

Face Value: 2

Credit Report: View PDF

NATCOPHARM - Price Chart

Volume Chart

Last 30 Days Bulk Deals

SL#	Symbol	Name	Date	Client	Buy/Sell	Quantity	Price	Remark
1	NATCOPHARM	Natco Pharma Limited	26/11/2025	GRAVITON RESEARCH CAPITAL LLP	SELL	1,199,411	905	-
2	NATCOPHARM	Natco Pharma Limited	26/11/2025	GRAVITON RESEARCH CAPITAL LLP	BUY	1,199,044	904	-
SL#	Symbol	Name	Date	Client	Buy/Sell	Quantity	Price	Remark

Technical Indicators

Today's OPEN >= LOW and HIGH=CLOSE	No
Is a 7 Days Breakout ?	No
3 Days Consecutive Volume Spike:	No
2 Days Consecutive Price Hike:	No
Above 20 MA ?	Above
Above 50 MA ?	Below
Above 100 MA ?	Below
Above 200 MA ?	Below

Important Disclaimer

One Page Analysis is calculated on the basis of Technical factors. No News or Result-oriented factors were considered.

This is a free tool only to help traders on a technical basis.

* Consult your financial advisor before investing in a strong market as it is subject to high risk.

One Page Analysis